XML 51 R40.htm IDEA: XBRL DOCUMENT
v3.25.1

Note 17 - Earnings Per Share (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2025
Notes Tables |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | March 31, |  |  | March 31, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | (in thousands, except share and per share data) |
BASIC |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerators: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) from continuing operations |  | $ | 3,940 |  |  | $ | (2,288 | ) |  | $ | 5,698 |  |  | $ | (9,142 | )
Net income (loss) from discontinued operations, net of tax |  |  | 54 |  |  |  | (599 | ) |  |  | 558 |  |  |  | (2,085 | )
Net income (loss) |  | $ | 3,994 |  |  | $ | (2,887 | ) |  | $ | 6,256 |  |  | $ | (11,227 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic weighted-average common shares outstanding |  |  | 6,134,634 |  |  |  | 5,533,555 |  |  |  | 6,111,550 |  |  |  | 5,511,089 |
Per share calculations: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) per share from continuing operations |  | $ | 0.64 |  |  | $ | (0.41 | ) |  | $ | 0.93 |  |  | $ | (1.66 | )
Net income (loss) per share from discontinued operations, net of tax |  | $ | 0.01 |  |  | $ | (0.11 | ) |  | $ | 0.09 |  |  | $ | (0.38 | )
Net income (loss) per share |  | $ | 0.65 |  |  | $ | (0.52 | ) |  | $ | 1.02 |  |  | $ | (2.04 | )
|  | Three Months Ended |  |  | Nine Months Ended |
|  | March 31, |  |  | March 31, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | (in thousands, except share and per share data) |
DILUTED: CONTINUING OPERATIONS |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) from continuing operations |  | $ | 3,940 |  |  | $ | (2,288 | ) |  | $ | 5,698 |  |  | $ | (9,142 | )
Adjustment for change in fair value of warrant liabilities |  |  | (2,261 | ) |  |  | — |  |  |  | (8,157 | ) |  |  | — |
Adjusted numerator - net income (loss) from continuing operations |  | $ | 1,679 |  |  | $ | (2,288 | ) |  | $ | (2,459 | ) |  | $ | (9,142 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic weighted-average common shares outstanding |  |  | 6,134,634 |  |  |  | 5,533,555 |  |  |  | 6,111,550 |  |  |  | 5,511,089 |
Dilutive effect of warrants to purchase common stock |  |  | 2,060,510 |  |  |  | — |  |  |  | 2,482,368 |  |  |  | — |
Dilutive effect of unvested restricted stock |  |  | 9,309 |  |  |  | — |  |  |  | 12,095 |  |  |  | — |
Diluted weighted-average common shares outstanding |  |  | 8,204,453 |  |  |  | 5,533,555 |  |  |  | 8,606,013 |  |  |  | 5,511,089 |
Per share calculation: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) per share from continuing operations |  | $ | 0.20 |  |  | $ | (0.41 | ) |  | $ | (0.29 | ) |  | $ | (1.66 | )
DILUTED: DISCONTINUED OPERATIONS |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) from discontinued operations, net of tax |  | $ | 54 |  |  | $ | (599 | ) |  | $ | 558 |  |  | $ | (2,085 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic weighted-average common shares outstanding |  |  | 6,134,634 |  |  |  | 5,533,555 |  |  |  | 6,111,550 |  |  |  | 5,511,089 |
Dilutive effect of warrants to purchase common stock |  |  | 2,060,510 |  |  |  | — |  |  |  | 2,482,368 |  |  |  | — |
Dilutive effect of unvested restricted stock |  |  | 9,309 |  |  |  | — |  |  |  | 12,095 |  |  |  | — |
Diluted weighted-average common shares outstanding |  |  | 8,204,453 |  |  |  | 5,533,555 |  |  |  | 8,606,013 |  |  |  | 5,511,089 |
Per share calculation: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) per share from discontinued operations, net of tax |  | $ | 0.01 |  |  | $ | (0.11 | ) |  | $ | 0.06 |  |  | $ | (0.38 | )
DILUTED: NET INCOME (LOSS) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) |  | $ | 3,994 |  |  | $ | (2,887 | ) |  | $ | 6,256 |  |  | $ | (11,227 | )
Adjustment for change in fair value of warrant liabilities |  |  | (2,261 | ) |  |  | — |  |  |  | (8,157 | ) |  |  | — |
Adjusted numerator - net income (loss) |  | $ | 1,733 |  |  | $ | (2,887 | ) |  | $ | (1,901 | ) |  | $ | (11,227 | )
Denominator: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic weighted-average common shares outstanding |  |  | 6,134,634 |  |  |  | 5,533,555 |  |  |  | 6,111,550 |  |  |  | 5,511,089 |
Dilutive effect of warrants to purchase common stock |  |  | 2,060,510 |  |  |  | — |  |  |  | 2,482,368 |  |  |  | — |
Dilutive effect of unvested restricted stock |  |  | 9,309 |  |  |  | — |  |  |  | 12,095 |  |  |  | — |
Diluted weighted-average common shares outstanding |  |  | 8,204,453 |  |  |  | 5,533,555 |  |  |  | 8,606,013 |  |  |  | 5,511,089 |
Per share calculation: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income (loss) per share |  | $ | 0.21 |  |  | $ | (0.52 | ) |  | $ | (0.22 | ) |  | $ | (2.04 | )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] |
|  | Three Months Ended |  |  | Nine Months Ended |
|  | March 31, |  |  | March 31, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Warrants to purchase common stock - liability classified (note 16) |  |  | 3,821,256 |  |  |  | 6,461,976 |  |  |  | 3,399,398 |  |  |  | 6,461,976 |
Warrants to purchase common stock - equity classified (note 16) |  |  | 15,571 |  |  |  | 18,114 |  |  |  | 15,571 |  |  |  | 18,114 |
Employee unvested restricted stock (note 15) |  |  | 25,223 |  |  |  | 31,897 |  |  |  | 22,437 |  |  |  | 31,897 |
Employee unvested restricted stock units (note 15) |  |  | 84 |  |  |  | 2,336 |  |  |  | 84 |  |  |  | 2,336 |
Employee stock options (note 15) |  |  | 219,244 |  |  |  | 146,701 |  |  |  | 219,244 |  |  |  | 146,701 |
Total anti-dilutive securities |  |  | 4,081,378 |  |  |  | 6,661,024 |  |  |  | 3,656,734 |  |  |  | 6,661,024 |

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_TableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration